L-arginine in Treatment of Intrauterine Growth Restriction

• Status: Unknown status
• Trial end date: 2018-12-30
• Target enrollment: 0
• Participant gender: Female

Summary

Intrauterine growth restriction is an important problem in neonatal care. Intrauterine growth restriction (IUGR) is defined as a fetal weight below the 10th percentile for gestational age. One of the main causes of IUGR is placental insufficiency.

Nitric oxide(NO) increases placental blood flow. So,it might be useful to improve IUGR pregnancy outcome .

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University
• Treatments: Aspirin

Criteria

Inclusion Criteria:

• All pregnant women diagnosed with IUGR from 28 weeks

• Singleton pregnancy

• No maternal systemic disease

• No congenital fetal malformation

• Estimated fetal weight below 10th percentile

Exclusion Criteria:

• All pregnant woman diagnosed with IUGR before 28 weeks

• Multiple pregnancy

• Maternal systemic disease

• Congenital fetal malformation